New Research Suggests GLP-1 Weight-Loss Drugs May Reduce Biological Age
Recent studies presented at a Boston conference indicate that overweight and diabetic individuals taking GLP-1 weight-loss drugs exhibit biomarkers of a biological age two to three years younger than their peers. This finding highlights the expanding scope of understanding regarding the systemic and long-term physiological side effects of these popular medications beyond simple weight management.
Source: MIT Tech Review